Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1+ stem cells from bone-marrow microenvironment

被引:482
作者
Hattori, K
Heissig, B
Wu, Y
Dias, S
Tejada, R
Ferris, B
Hicklin, DJ
Zhu, ZP
Bohlen, P
Witte, L
Hendrikx, J
Hackett, NR
Crystal, RG
Moore, MAS
Werb, Z
Lyden, D
Rafii, S [1 ]
机构
[1] Cornell Univ, Coll Med, Dept Med, New York, NY 10021 USA
[2] Sloan Kettering Inst, New York, NY USA
[3] ImClone Syst Inc, New York, NY USA
[4] New York Blood Ctr, New York, NY 10021 USA
[5] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA
关键词
D O I
10.1038/nm740
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanism by which angiogenic factors recruit bone marrow ( BM)-derived quiescent endothelial and hematopoietic stem cells ( HSCs) is not known. Here, we report that functional vascular endothelial growth factor receptor-1 (VEGFR1) is expressed on human CD34(+) and mouse Lin(-)Sca-1(+)c-Kit(+) BM-repopulating stem cells, conveying signals for recruitment of HSCs and reconstitution of hematopoiesis. Inhibition of VEGFR1, but not VEGFR2, blocked HSC cell cycling, differentiation and hematopoietic recovery after BM suppression, resulting in the demise of the treated mice. Placental growth factor ( PlGF), which signals through VEGFR1, restored early and late phases of hematopoiesis following BM suppression. PlGF enhanced early phases of BM recovery directly through rapid chemotaxis of VEGFR1(+) BM-repopulating and progenitor cells. The late phase of hematopoietic recovery was driven by PlGF-induced upregulation of matrix metalloproteinase-9, mediating the release of soluble Kit ligand. Thus, PlGF promotes recruitment of VEGFR1(+) HSCs from a quiescent to a proliferative BM microenvironment, favoring differentiation, mobilization and reconstitution of hematopoiesis.
引用
收藏
页码:841 / 849
页数:9
相关论文
共 42 条
  • [1] Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1
    Barleon, B
    Sozzani, S
    Zhou, D
    Weich, HA
    Mantovani, A
    Marme, D
    [J]. BLOOD, 1996, 87 (08) : 3336 - 3343
  • [2] FUNCTIONAL ISOLATION AND CHARACTERIZATION OF HUMAN HEMATOPOIETIC STEM-CELLS
    BERARDI, AC
    WANG, AL
    LEVINE, JD
    LOPEZ, P
    SCADDEN, DT
    [J]. SCIENCE, 1995, 267 (5194) : 104 - 108
  • [3] BRIDDELL RA, 1993, BLOOD, V82, P1720
  • [4] Broxmeyer HE, 1995, INT J HEMATOL, V62, P203
  • [5] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [6] Angiogenesis in cancer and other diseases
    Carmeliet, P
    Jain, RK
    [J]. NATURE, 2000, 407 (6801) : 249 - 257
  • [7] Hematopoietic stem cell quiescence maintained by p21cip1/waf1
    Cheng, T
    Rodrigues, N
    Shen, HM
    Yang, YG
    Dombkowski, D
    Sykes, M
    Scadden, DT
    [J]. SCIENCE, 2000, 287 (5459) : 1804 - 1808
  • [8] Developmental control of blood cell migration by the Drosophila VEGF pathway
    Cho, NK
    Keyes, L
    Johnson, E
    Heller, J
    Ryner, L
    Karim, F
    Krasnow, MA
    [J]. CELL, 2002, 108 (06) : 865 - 876
  • [9] The vascular endothelial growth factor receptor Flt-1 mediates biological activities - Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis
    Clauss, M
    Weich, H
    Breier, G
    Knies, U
    Rockl, W
    Waltenberger, J
    Risau, W
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (30) : 17629 - 17634
  • [10] Inhibition of both paracrine and autocrine VEGF/VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias
    Dias, S
    Hattori, K
    Heissig, B
    Zhu, ZP
    Wu, Y
    Witte, L
    Hicklin, DJ
    Tateno, M
    Bohlen, P
    Moore, MAS
    Rafii, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (19) : 10857 - 10862